This week’s newsletter covers cannabis rescheduling, hemp regulation enforcement hurdles, promising cannabinoid research for Alzheimer’s disease and hypertension, CBD use trends on college campuses, the environmental toll of drug prohibition, and the WHO’s new push to evaluate traditional medicines.
Noteworthy Read
Microdosing Cannabis: A New Hope for Alzheimer’s Patients (PsyPost)
In a recent study out of Brazil, researchers report that very low doses of THC and CBD improved memory, reduced neuroinflammation, and slowed disease progression in Alzheimer’s models, adding to the evidence supporting cannabinoids as a potential therapeutic option for the disease.
Read more
View more in THC
More Noteworthy Reading
CBD Reduces Blood Pressure in Patients With Hypertension (NORML)
A randomized clinical trial found that daily CBD dosing significantly reduced resting and ambulatory blood pressure in patients with hypertension, suggesting CBD may offer cardiovascular benefits beyond stress reduction.
Read more
View more in CBD
CBD Use Is Common on College Campuses (Star City News)
Reporting based on student surveys and campus interviews finds that CBD use is widespread among college students, driven by perceptions of stress relief, sleep support, and legality — often with little awareness of dosing or product quality.
Read more
View more in CBD
How Drug Prohibition Drives the Climate Crisis (Filter Magazine)
This insightful editorial argues that drug prohibition fuels environmental destruction through illegal deforestation, toxic chemical dumping, militarized enforcement, and disrupted Indigenous land stewardship, linking drug policy reform to climate justice.
Read more
View more in Synthetic Cannabinoids
“A Potential Treasure Trove”: WHO to Explore Benefits of Traditional Medicines (The Guardian)
The World Health Organization announced new efforts to systematically evaluate traditional medicines as part of mainstream healthcare, citing untapped therapeutic potential alongside the need for evidence-based standards.
Read more
View more in Psychedelics
A heartfelt thank you to all of the CBD brands whose generous support makes it possible for Project CBD to bring you the latest in plant medicine research and reporting — we couldn’t do this work without you.
Be the first to comment